(Q43767922)

26 November 2017

Differential effects of HIV-1 protease inhibitors on dendritic cell immunophenotype and function (English)

1 reference

26 November 2017

1 reference

5

Wong-Staal F

1 reference

26 November 2017

Gruber A

1

1 reference

26 November 2017

Wheat JC

series ordinal

2

1 reference

26 November 2017

Kuhen KL

series ordinal

3

1 reference

26 November 2017

Looney DJ

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

15 October 2001

1 reference

Journal of Biological Chemistry

26 November 2017

1 reference

26 November 2017

276

1 reference

26 November 2017

47840-47843

1 reference

26 November 2017

51

1 reference

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

26 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Effect of a human immunodeficiency virus protease inhibitor on human monocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir but not indinavir impair the epithelial barrier in the human intestinal cell line HT-29/B6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

How an inhibitor of the HIV-I protease modulates proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

HIV treatment failure: testing for HIV resistance in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Cathepsins and compartmentalization in antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

A new reporter cell line to monitor HIV infection and drug susceptibility in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

HIV-1 protease does not play a critical role in the early stages of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Altered immunophenotype of dendritic cells generated from HIV infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105582200

21 January 2018

Identifiers

DOI

10.1074/JBC.M105582200

0 references

1 reference